Skip to main content

Azenta Inc

Exchange: NASDAQSector: HealthcareIndustry: Medical Instruments & Supplies

Brooks operates two global, market-leading businesses, Life Sciences and Semiconductor Solutions, each with its own distinct area of focus and expertise. The Life Sciences business, to be operated under the new Azenta brand, provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. On September 20, 2021, the Company announced the pending sale to Thomas H. Lee Partners of its Semiconductor Solutions Group business, which provides industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers as well as collaborative robotics and automation capabilities for multi-market applications. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia.

Did you know?

Generated $1.1 in free cash flow for every $1 of capital expenditure in FY25.

Current Price

$24.91

+1.38%

GoodMoat Value

$30.79

23.6% undervalued
Profile
Valuation (TTM)
Market Cap$1.14B
P/E-19.71
EV
P/B0.66
Shares Out45.78M
P/Sales1.92
Revenue$594.95M
EV/EBITDA

Azenta Inc (AZTA) Company Profile

AZTA Company Information

Brooks operates two global, market-leading businesses, Life Sciences and Semiconductor Solutions, each with its own distinct area of focus and expertise.

The Life Sciences business, to be operated under the new Azenta brand, provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.

On September 20, 2021, the Company announced the pending sale to Thomas H.

Lee Partners of its Semiconductor Solutions Group business, which provides industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers as well as collaborative robotics and automation capabilities for multi-market applications.

Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

Country

Massachusetts, USA

AZTA Key Officers

Key officers data coming soon

AZTA Company Profile

Azenta Inc (AZTA) is a Healthcare company in the Medical Instruments & Supplies industry. It trades on NASDAQ. The company is based in Massachusetts, USA.

Brooks operates two global, market-leading businesses, Life Sciences and Semiconductor Solutions, each with its own distinct area of focus and expertise. The Life Sciences business, to be operated under the new Azenta brand, provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. On September 20, 2021, the Company announced the pending sale to Thomas H. Lee Partners of its Semiconductor Solutions Group business, which provides industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers as well as collaborative robotics and automation capabilities for multi-market applications. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia.

Market cap is $1.14B. There are 45.8M shares outstanding.

See the full Azenta Inc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if AZTA is a good investment.